Browse by Journal Title

2023

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: pathological and clinical aspects.
Samadzadeh, S., Olesen, M.N., Wirenfeldt, M., Möller, S., Misu, T., Soelberg, K., Frederiksen, J.L., Heegaard, S., Mariotto, S., Fujihara, K., Ruprecht, K., Andersen, T.L., Marignier, R., Lillevang, S.T., Flanagan, E.P., Pittock, S.J., Kim, H.J., Bennett, J.L., Paul, F., Sorensen, G.L., Weinshenker, B.G., Lassmann, H. and Asgari, N.
Multiple Sclerosis Journal 29 (14): 1721-1735. 14 December 2023

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Vrech, C., Zarate, M.A., Correale, J., Deri, N., Luetic, G., Marrodan, M., Pagani Cassara, F., Tavolini, D., Ysrraelit, M.C., Balbuena, M.E., Hryb, J., Chiganer, E., Leguizamon, F., Knorre, E., Zanga, G., Pestchanker, C., Barboza, A., Nadur, D., Cristiano, E., Patrucco, L., Alonso, R., Alonso Serena, M., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal 29 (10): 1240-1249. September 2023

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Lotan, I., Chen, J.J., Hacohen, Y., Abdel-Mannan, O., Mariotto, S., Huda, S., Gibbons, E., Wilf-Yarkoni, A., Hellmann, M.A., Stiebel-Kalish, H., Pittock, S.J., Flanagan, E.P., Molazadeh, N., Anderson, M., Salky, R., Romanow, G., Schindler, P., Duchow, A.S., Paul, F. and Levy, M.
Multiple Sclerosis Journal 29 (9): 1080-1089. August 2023

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Bennett, J.L., Kim, H.J., Pittock, S.J., Fujihara, K., Paul, F., Cutter, G., Marignier, R., Aktas, O., Hartung, H.P., She, D., Smith, M., Rees, W., Patterson, K., Cimbora, D., Katz, E. and Cree, B.A.
Multiple Sclerosis Journal 29 (8): 945-955. July 2023

Cognition in patients with neuromyelitis optica spectrum disorders: a prospective multicentre study of 217 patients (CogniNMO-Study).
Hümmert, M.W., Stern, C., Paul, F., Duchow, A., Bellmann-Strobl, J., Ayzenberg, I., Schwake, C., Kleiter, I., Hellwig, K., Jarius, S., Wildemann, B., Senel, M., Berthele, A., Giglhuber, K., Luessi, F., Grothe, M., Klotz, L., Schülke, R., Gingele, S., Faiss, J.H., Walter, A., Warnke, C., Then Bergh, F., Aktas, O., Ringelstein, M., Stellmann, J.P., Häußler, V., Havla, J., Pellkofer, H., Kümpfel, T., Kopp, B. and Trebst, C.
Multiple Sclerosis Journal 29 (7): 819-831. June 2023

2022

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Meaton, I., Altokhis, A., Allen, C.M., Clarke, M.A., Sinnecker, T., Meier, D., Enzinger, C., Calabrese, M., De Stefano, N., Pitiot, A., Giorgio, A., Schoonheim, M.M., Paul, F., Pawlak, M.A., Schmidt, R., Granziera, C., Kappos, L., Montalban, X., Rovira, À., Wuerfel, Jens and Evangelou, N.
Multiple Sclerosis Journal 28 (14): 2212-2220. December 2022

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
Brune, S., Høgestøl, E.A., de Rodez Benavent, S.A., Berg-Hansen, P., Beyer, M.K., Leikfoss, I.S., Bos, S.D., Sowa, P., Brunborg, C., Andorra, M., Pulido Valdeolivas, I., Asseyer, S., Brandt, A., Chien, C., Scheel, M., Blennow, K., Zetterberg, H., Kerlero de Rosbo, N., Paul, F., Uccelli, A., Villoslada, P., Berge, T. and Harbo, H.F.
Multiple Sclerosis Journal 28 (12): 1859-1870. October 2022

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ayadi, N., Oertel, F.C., Asseyer, S., Rust, R., Duchow, A., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Klistorner, A., Brandt, A.U., Paul, F. and Zimmermann, H.G.
Multiple Sclerosis Journal 28 (5): 757-767. April 2022

2021

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.
Cooper, G., Chien, C., Zimmermann, H., Bellmann-Strobl, J., Ruprecht, K., Kuchling, J., Asseyer, S., Brandt, A.U., Scheel, M., Finke, C. and Paul, F.
Multiple Sclerosis Journal 27 (14): 2180-2190. December 2021

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 27 (13): 2052-2061. 1 November 2021

Functional connectivity alterations of striato-cortical circuits in multiple sclerosis.
Jaeger, S., Paul, F. and Finke, C.
Multiple Sclerosis Journal 27 (9): 1469-1470. 1 August 2021

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - commentary.
Paul, F.
Multiple Sclerosis Journal 27 (1): 16-18. 1 January 2021

2019

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien, C., Scheel, M., Schmitz-Hübsch, T., Borisow, N., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 25 (14): 1926-1936. December 2019

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
Graetz, C., Gröger, A., Luessi, F., Salmen, A., Zöller, D., Schultz, J., Siller, N., Fleischer, V., Bellenberg, B., Berthele, A., Biberacher, V., Havla, J., Hecker, M., Hohlfeld, R., Infante-Duarte, C., Kirschke, J.S., Kümpfel, T., Linker, R., Paul, F., Pfeuffer, S., Sämann, P., Toenges, G., Weber, F., Zettl, U.K., Jahn-Eimermacher, A., Antony, G., Groppa, S., Wiendl, H., Hemmer, B., Mühlau, M., Lukas, C., Gold, R., Lill, C.M. and Zipp, F.
Multiple Sclerosis Journal 25 (5): 661-668. 1 April 2019

Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
Jaeger, S., Paul, F., Scheel, M., Brandt, A., Heine, J., Pach, D., Witt, C.M., Bellmann-Strobl, J. and Finke, C.
Multiple Sclerosis Journal 25 (4): 554-564. April 2019

2018

Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders.
Mealy, M.A., Kim, S.H., Schmidt, F., López, R., Jimenez Arango, J.A., Paul, F., Wingerchuk, D.M., Greenberg, B.M., Kim, H.Jin. and Levy, M.
Multiple Sclerosis Journal 24 (13): 1737-1742. 1 November 2018

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.
Weygandt, M., Wakonig, K., Behrens, J., Meyer-Arndt, L., Söder, E., Brandt, A.U., Bellmann-Strobl, J., Ruprecht, K., Gold, S.M., Haynes, J.D. and Paul, F.
Multiple Sclerosis Journal 24 (9): 1163-1173. 1 August 2018

2017

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.
Mikolajczak, J., Zimmermann, H., Kheirkhah, A., Kadas, E.M., Oberwahrenbrock, T., Muller, R., Ren, A., Kuchling, J., Dietze, H., Prüss, H., Paul, F., Hamrah, P. and Brandt, A.U.
Multiple Sclerosis Journal 23 (14): 1847-1853. 1 December 2017

A population-based prospective study of optic neuritis.
Soelberg, K., Jarius, S., Skejoe, H.P.B., Engberg, H., Mehlsen, J.J., Nilsson, A.C., Madsen, J.S., Reindl, M., Wildemann, B., Grauslund, J., Kyvik, K.O., Smith, T.J., Lillevang, S.T., Paul, F., Weinshenker, B.G. and Asgari, N.
Multiple Sclerosis Journal 23 (14): 1893-1901. 1 December 2017

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Borisow, N., Kleiter, I., Gahlen, A., Fischer, K., Wernecke, K.D., Pache, F., Ruprecht, K., Havla, J., Krumbholz, M., Kümpfel, T., Aktas, O., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Weissert, R., Stellmann, J.P., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Zeltner, L., Ziemann, U., Linker, R.A., Schwab, M., Marziniak, M., Then Bergh, F., Hofstadt-van Oy, U., Neuhaus, O., Winkelmann, A., Marouf, W., Rückriem, L., Faiss, J., Wildemann, B., Paul, F., Jarius, S., Trebst, C. and Hellwig, K.
Multiple Sclerosis Journal 23 (8): 1092-1103. July 2017

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm, L., Chien, C., Bellmann-Strobl, J., Dörr, J., Wuerfel, J., Brandt, A.U., Paul, F. and Scheel, M.
Multiple Sclerosis Journal 23 (7): 963-972. June 2017

Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.
Bühler, U., Fleischer, V., Luessi, F., Rezk, A., Belikan, P., Graetz, C., Gollan, R., Wolf, C., Lutz, J., Bar-Or, A., Siffrin, V. and Zipp, F.
Multiple Sclerosis Journal 23 (4): 567-576. 1 April 2017

2016

Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.
Behrens, J.R., Mertens, S., Krüger, T., Grobelny, A., Otte, K., Mansow-Model, S., Gusho, E., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
Multiple Sclerosis Journal 22 (12): 1596-1606. October 2016

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
Hasselmann, H., Bellmann-Strobl, J., Ricken, R., Oberwahrenbrock, T., Rose, M., Otte, C., Adli, M., Paul, F., Brandt, A.U., Finke, C. and Gold, S.M.
Multiple Sclerosis Journal 22 (11): 1476-1484. October 2016

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Jarius, S., Metz, I., König, F.B., Ruprecht, K., Reindl, M., Paul, F., Brück, W. and Wildemann, B.
Multiple Sclerosis Journal 22 (12): 1541-1549. October 2016

PML risk stratification using anti-JCV antibody index and L-selectin.
Schwab, N., Schneider-Hohendorf, T., Pignolet, B., Spadaro, M., Görlich, D., Meinl, I., Windhagen, S., Tackenberg, B., Breuer, J., Cantó, E., Kümpfel, T., Hohlfeld, R., Siffrin, V., Luessi, F., Posevitz-Fejfár, A., Montalban, X., Meuth, S.G., Zipp, F., Gold, R., Du Pasquier, R.A., Kleinschnitz, C., Jacobi, A., Comabella, M., Bertolotto, A., Brassat, D. and Wiendl, H.
Multiple Sclerosis Journal 22 (8): 1048-1060. July 2016

Placebo-controlled study in neuromyelitis optica : ethical and design considerations.
Cree, B.A.C., Bennett, J.L., Sheehan, M., Cohen, J., Hartung, H.P., Aktas, O., Kim, H.J., Paul, F., Pittock, S., Weinshenker, B., Wingerchuk, D., Fujihara, K., Cutter, G., Patra, K., Flor, A., Barron, G., Madani, S., Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 22 (7): 862-872. June 2016

Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
Nemecek, A., Zimmermann, H., Rübenthaler, J., Fleischer, V., Paterka, M., Luessi, F., Müller-Forell, W., Zipp, F. and Siffrin, V.
Multiple Sclerosis Journal 22 (4): 483-493. April 2016

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Hertwig, L., Pache, F., Romero-Suarez, S., Stuerner, K.H., Borisow, N., Behrens, J., Bellmann-Strobl, J., Seeger, B., Asselborn, N., Ruprecht, K., Millward, J.M., Infante-Duarte, C. and Paul, F.
Multiple Sclerosis Journal 22 (2): 160-173. February 2016

2015

Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue.
Finke, C., Schlichting, J., Papazoglou, S., Scheel, M., Freing, A., Soemmer, C., Pech, L.M., Pajkert, A., Pfueller, C.J., Wuerfel, J.T., Ploner, C., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 21 (7): 925-934. June 2015

Demographic and clinical features of neuromyelitis optica: A review.
Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M.I., Kleiter, I. and Chitnis, T.
Multiple Sclerosis Journal 21 (7): 845-853. June 2015

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
Bennett, J.L., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., Fujihara, K., Chan, K.H., Kim, H.J., Asgari, N., Sato, D.K., Saiz, A., Wuerfel, J., Zimmermann, H., Green, A., Villoslada, P. and Paul, F.
Multiple Sclerosis Journal 21 (6): 678-688. May 2015

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.
Kotelnikova, E., Bernardo-Faura, M., Silberberg, G., Kiani, N.A., Messinis, D., Melas, I.N., Artigas, L., Schwartz, E., Mazo, I., Masso, M., Alexopoulos, L.G., Mas, J.M., Olsson, T., Tegner, J., Martin, R., Zamora, A., Paul, F., Saez-Rodriguez, J. and Villoslada, P.
Multiple Sclerosis Journal 21 (2): 138-146. February 2015

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Schippling, S., Balk, L., Costello, F., Albrecht, P., Balcer, L., Calabresi, P., Frederiksen, J., Frohman, E., Green, A., Klistorner, A., Outteryck, O., Paul, F., Plant, G., Traber, G., Vermersch, P., Villoslada, P., Wolf, S. and Petzold, A.
Multiple Sclerosis Journal 21 (2): 163-170. February 2015

2014

Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Kuchling, J., Ramien, C., Bozin, I., Dörr, J., Harms, L., Rosche, B., Niendorf, T., Paul, F., Sinnecker, T. and Wuerfel, J.
Multiple Sclerosis Journal 20 (14): 1866-1871. December 2014

Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: a combined optical coherence tomography and diffusion tensor imaging study.
Scheel, M., Finke, C., Oberwahrenbrock, T., Freing, A., Pech, L.M., Schlichting, J., Sömmer, C., Wuerfel, J., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 20 (14): 1904-1907. December 2014

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Kremer, L., Mealy, M., Jacob, A., Nakashima, I., Cabre, P., Bigi, S., Paul, F., Jarius, S., Aktas, O., Elsone, L., Mutch, K., Levy, M., Takai, Y., Collongues, N., Banwell, B., Fujihara, K. and de Seze, J.
Multiple Sclerosis Journal 20 (7): 843-847. June 2014

Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein, M., Metz, I., Ruprecht, K., Koch, A., Rappold, J., Ingwersen, J., Mathys, C., Jarius, S., Brück, W., Hartung, H.P., Paul, F. and Aktas, O.
Multiple Sclerosis Journal 20 (7): 882-888. June 2014

Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
Ringelstein, M., Kleiter, I., Ayzenberg, I., Borisow, N., Paul, F., Ruprecht, K., Kraemer, M., Cohn, E., Wildemann, B., Jarius, S., Hartung, H.P., Aktas, O. and Albrecht, P.
Multiple Sclerosis Journal 20 (5): 617-620. April 2014

How to treat tumefactive demyelinating disease?
Siffrin, V., Müller-Forell, W., von Pein, H. and Zipp, F.
Multiple Sclerosis Journal 20 (5): 631-633. April 2014

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller, A., Leidinger, P., Steinmeyer, F., Stähler, C., Franke, A., Hemmrich-Stanisak, G., Kappel, A., Wright, I., Dörr, J., Paul, F., Diem, R., Tocariu-Krick, B., Meder, B., Backes, C., Meese, E. and Ruprecht, K.
Multiple Sclerosis Journal 20 (3): 295-303. March 2014

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Collongues, N., Marignier, R., Jacob, A., Leite, M., Siva, A., Paul, F., Zephir, H., Akman-Demir, G., Elsone, L., Jarius, S., Papeix, C., Mutch, K., Saip, S., Wildemann, B., Kitley, J., Karabudak, R., Aktas, O., Kuscu, D., Altintas, A., Palace, J., Confavreux, C. and De Seze, J.
Multiple Sclerosis Journal 20 (8): 1086-1094. 2014

2013

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Oberwahrenbrock, T., Ringelstein, M., Jentschke, S., Deuschle, K., Klumbies, K., Bellmann-Strobl, J., Harmel, J., Ruprecht, K., Schippling, S., Hartung, H.P., Aktas, O., Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal 19 (14): 1887-1895. December 2013

Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Deuschle, K., Hofmann, J., Otto, C., Bellmann-Strobl, J., Scherner, O., Klumbies, K., Schneider, E., Broddack, J., Paul, F. and Ruprecht, K.
Multiple Sclerosis Journal 19 (9): 1242-1243. August 2013

Breastfeeding is associated with lower risk for multiple sclerosis.
Conradi, S., Malzahn, U., Paul, F., Quill, S., Harms, L., Then Bergh, F., Ditzenbach, A., Georgi, T., Heuschmann, P. and Rosche, B.
Multiple Sclerosis Journal 19 (5): 553-558. April 2013

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Zimmermann, H., Freing, A., Kaufhold, F., Gaede, G., Bohn, E., Bock, M., Oberwahrenbrock, T., Young, K.L., Dörr, J., Wuerfel, J.T., Schippling, S., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 19 (4): 443-450. April 2013

Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Sinnecker, T., Bozin, I., Dörr, J., Pfueller, C.F., Harms, L., Niendorf, T., Brandt, A.U., Paul, F. and Wuerfel, J.
Multiple Sclerosis Journal 19 (3): 316-325. March 2013

'Obstructive sleep apnea is associated with fatigue in multiple sclerosis' by Kaminska et al.
Veauthier, C., Blau, A. and Paul, F.
Multiple Sclerosis Journal 19 (3): 372-373. March 2013

2012

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Wuerfel, J., Sinnecker, T., Ringelstein, E.B., Jarius, S., Schwindt, W., Niendorf, T., Paul, F., Kleffner, I. and Doerr, J.
Multiple Sclerosis Journal 18 (11): 1592-1599. November 2012

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
Jarius, S., Paul, F., Franciotta, D., de Seze, J., Muench, C., Salvetti, M., Ruprecht, K., Liebetrau, M., Wandinger, K., Akman-Demir, G., Melms, A., Kristoferitsch, W. and Wildemann, B.
Multiple Sclerosis Journal 18 (8): 1135-1143. August 2012

Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Veauthier, C. and Paul, F.
Multiple Sclerosis Journal 18 (2): 248-249. February 2012

2011

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius, S., Jacobi, C., de Seze, J., Zephir, H., Paul, F., Franciotta, D., Rommer, P., Mader, S., Kleiter, I., Reindl, M., Akman-Demir, G., Seifert-Held, T., Kristoferitsch, W., Melms, A., Wandinger, K.P. and Wildemann, B.
Multiple Sclerosis Journal 17 (9): 1067-1073. September 2011

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Veauthier, C., Radbruch, H., Gaede, G., Pfueller, C., Doerr, J., Bellmann-Strobl, J., Wernecke, K.D., Zipp, F., Paul, F. and Sieb, J.
Multiple Sclerosis Journal 17 (5): 613-622. May 2011